Erlotinib Stada

Erlotinib Stada is an oral medication used to treat certain types of cancer. This targeted therapy is designed to inhibit specific proteins involved in cancer cell growth.

Erlotinib Stada is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by targeting and blocking the activity of certain proteins that promote cancer cell growth. Patients often wonder, 'What is Erlotinib used for?' This medication is part of a class of drugs known as tyrosine kinase inhibitors, which help slow the progression of cancer.

Common effects of Erlotinib Stada may include skin rash, diarrhea, and fatigue. Some patients may also experience loss of appetite or nausea. These effects can vary in severity and may not affect everyone who takes the medication.

Erlotinib Stada should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their doctor about any other medications they are taking to avoid potential interactions.

Erlotinib Stada may interact with certain medications, including those that are metabolized by the liver. It is important to discuss all current medications with a healthcare provider to ensure safe use. Additionally, patients should avoid grapefruit and grapefruit juice, as they can affect how the body processes Erlotinib.